Moderna, Inc. (1MRNA)
MTA
Real-time Data
07:00 AM
Day's Range
112.1452 wk Range
19.38Overview - 1MRNA - Moderna, Inc.
Key Statistics
Valuation
Enterprise Value
40.79B
P/E (Trailing)
‪-17.66‬
PEG Ratio
‪2.35‬
Price / Sales (TTM)
‪23.11‬
Price / Book
‪8.89‬
EV / EBITDA
‪-21.70‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪-141.42%‬
Operating Margin
‪-557.93%‬
Return on Assets
‪-13.25%‬
Return on Equity
‪-38.99%‬
Ownership
Shares Outstanding
399.00M
Float
372.26M
Held by Insiders
‪7.31%‬
Held by Institutions
‪80.45%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪59.28‬
200-Day Avg
‪42.57‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1MRNA - Moderna, Inc.
Peers - 1MRNA - Moderna, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1MRNAMTAModerna, Inc.12.13BMarket Cap+82.82%52-week change-17.66P/E (Trailing)‪-141.42%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+28.94%52-week change20.61P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)41.80BMarket Cap+47.15%52-week change137.71P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
Profile Summary - 1MRNA - Moderna, Inc.
About
Moderna, Inc. is a biotechnology company focused on messenger RNA (mRNA) medicines and vaccines. Its portfolio centers on products for respiratory and infectious diseases, including COVID-19 and RSV vaccines, alongside a pipeline that extends into oncology, rare diseases, autoimmune disorders, and other therapeutic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
